Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sabin Göktaş Aydın"'
Autor:
Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, Mustafa Korkmaz, Dilek Erdem, Umut Cakıroglu, Mustafa Karaca, Ahmet Dirican, Omer Fatih Olmez, Sabin Goktas Aydın, Ali Gökyer, Ahmet Kücükarda, Ahmet Gülmez, Perran Fulden Yumuk, Nazim Can Demircan, Abdilkerim Oyman, Teoman Sakalar, Fatih Karatas, Hacer Demir, Ayse Irem Yasin, Adem Deligonul, Bahar Dakiki, Mehmet Refik Goktug, Okan Avcı, Seher Yildiz Tacar, Nazım Serdar Turhal, Gülhan Ipek Deniz, Turgut Kacan, Erdem Cubukcu, Türkkan Evrensel
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5195-5205 (2024)
Background: This study aimed to investigate the effect of cytoreductive nephrectomy (CN) on the survival outcomes of nivolumab used as a subsequent therapy after the failure of at least one anti-vascular endothelial growth factor (VEGF) agent in pati
Externí odkaz:
https://doaj.org/article/e3b91b5047204acf948136cd657f8dec
Publikováno v:
Acta Oncologica Turcica. 55:270-273
Autor:
Sabin Göktaş Aydın, Burçin Çakan Demirel, Ahmet Bilici, Cansu Yilmaz, Atakan Topçu, Musa Barış Aykan, Seda Kahraman, Muhammed Mustafa Atcı, Ilgın Akbıyık, Fahri Akgül, Ömer Fatih Ölmez, Ahmet Aydın
Introduction: There is a lack of evidence of the outcomes in elderly patients advanced stage biliary tract cancer due to the patients aged over 65 years are less than 25% in many prospective trials. We designed a retrospective multicenter study to ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a19e07c664da1df182010721d559aa60
https://hdl.handle.net/20.500.12511/11031
https://hdl.handle.net/20.500.12511/11031
Autor:
Sabin Göktaş Aydın, Yasin Kutlu, Harun Muğlu, Özgür Açıkgöz, Ahmet Aydın, Ahmet Bilici, Ömer Ölmez, Dilek Ünal, Ebru Karcı, Özcan Yıldız
Objective: Androgen pathway inhibitors have a significant impact on the treatment of prostate cancer. The treatment approach is controversial in patients who develop oligo-pro-gression under anti-androgen therapy. This study aimed to in-vestigate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::623dc948818f448cebe07abe4fc18153
https://hdl.handle.net/20.500.12511/11088
https://hdl.handle.net/20.500.12511/11088
Autor:
Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, Mustafa Korkmaz, Dilek Erdem, Umut Cakıroglu, Mustafa Karaca, Ahmet Dirican, Omer Fatih Olmez, Sabin Göktaş Aydın, Ali Gökyer, Ahmet Küçükarda, Ahmet Gülmez, Perran Fulden Yumuk, Nazim Can Demircan, Abdilkerim Oyman, Teoman Sakalar, Fatih Karataş, Hacer Demir, Ayse Irem Yasin, Adem Deligönül, Bahar Dakiki, Mehmet Refik Goktug, Okan Avcı, Seher Yildiz Tacar, Nazım Serdar Turhal, Gulhan Ipek Deniz, Turgut Kacan, Erdem Cubukcu, Türkkan Evrensel
Renal cell carcinoma is the fourteenth most common cancer in the world with a male to female ratio of 2:1, and clear cell renal cell carcinoma (ccRCC) is the most common histological subtype. Nivolumab is preferred as subsequent therapy in patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e5a15870b5d76209b99a5b795b3e4bc
https://doi.org/10.21203/rs.3.rs-1693977/v1
https://doi.org/10.21203/rs.3.rs-1693977/v1
Autor:
Emine Yıldırım, Sibel Bektaş, Sabin Göktaş Aydın, Ahmet Er, İrem Yanık, Perihan Özkan Gümüşkaya, Barbaros Yılmaz, Ahmet Bilici, Mustafa Öncel
Objective: In the treatment of local advanced gastric cancer (LAGC), it is recommended to start with neoadjuvant chemotherapy (NAC). Although the benefits of NAC have been shown, it is still not fully understood which patients respond better. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d30391978aa507d9f419ce0007ef06
https://hdl.handle.net/20.500.12511/9016
https://hdl.handle.net/20.500.12511/9016
Autor:
Sabin Göktaş Aydın, Mutlu Dogan, Neslihan Ozyurt, Baran Akagunduz, Sema Sezgin Goksu, Semra Paydas, Tugba Akin Telli, Muhammet Ozer, Cengiz Karacin, Hasan Cagri Yildirim
Publikováno v:
Cureus
Objectives Head and neck soft tissue sarcomas (HNSTSs) are a heterogeneous group of rare tumors. Surgical resection with negative margins remains the standard primary treatment for patients with HNSTS. The role of chemotherapy (CT) and radiotherapy (
Autor:
Mustafa Karaagac, Ali Murat Tatli, Mustafa Ozdogan, Ali Ayberk Besen, Ahmet Bilici, Sema Sezgin Goksu, Mustafa Atcı, Muhammet Ali Kaplan, Senar Ebinç, Mukremin Uysal, Sabin Göktaş Aydın, Hasan Şenol Coşkun, Mehmet Artac, Caglayan Geredeli, Huseyin Mertsoylu
Publikováno v:
Cancer chemotherapy and pharmacology. 88(5)
Purpose In this study, we looked for whether treatment-induced rash predicts treatment efficacy in patients with recurrent/metastatic HNSCC treated with Cetuximab and chemotherapy. Methods Patients who were treated with platinum-based chemotherapy an
Autor:
Sabin Göktaş Aydın, Ahmet Bilici, Ömer Fatih Ölmez, Cengiz Köksal, Ozgur Acikgoz, Jamshid Hamdard, Fethi Kilicaslan, Ayberk Bayramgil, Mehmet Seker, Ozcan Yildiz, Nur Buyukpinarbasili, Elkhan Mammadov
Publikováno v:
The breast journal. 27(1)
A 34-year-old woman had a history of breast cancer and underwent a right-sided nipple-sparing mastectomy and axillary dissection in 2014. She was staged as pT2N2aM0, IIIA, and the histopathological type was TNBC, grade 3. Ki-67 index was 35%-40%. The
Autor:
Sabin Göktaş Aydın, Bahar Artım Esen
Publikováno v:
RAED Dergisi. 10:6-13